Interventional radiology procedures are increasingly in demand in both the adult and pediatric populations. Pediatric procedures mirror many of the adult procedures but with increased complexity due to many considerations, notably patient size. This article reviews the various vascular pediatric interventional procedures. The aim is to provide a greater exposure to the possible treatment options for pediatric patients and to facilitate understanding of the success and complications rates related to various interventions.
Peripherally Inserted Central Catheter
Peripherally inserted central catheters (PICCs) provide good intermediate-term venous access, typically for a period of several weeks. There are various types of PICCs, with different French diameters and number of lumens. The 3F or 4F catheters are reasonable for most pediatric patients. The PowerPICC (Bard Access Systems, Salt Lake City, UT) is designed to allow power injection for contrast-enhanced computed tomography (CT) imaging.
PICCs are ideally positioned in the nondependent arm, often with the basilic vein as the primary site for access. The cutaneous access point should be above the elbow to facilitate comfortable elbow movement and avoid kinking. The tip of the PICC ideally should be at the right atrialcaval junction, which is just below the inferior edge of the right main stem bronchus or the sixth posterior intercostal space [1, 6] . In young children, the PICC tip can be move, depending on arm position, and this should be assessed at the time of insertion (Figure 1) . A catheter situated within the right atrium can result in several complications, including fatal cardiac tamponade [1] . The PICC should remain in place until venous access is no longer needed. If it becomes blocked or displaced, it should not be removed before an attempt at reinsertion. It is much easier to place a new PICC with one in situ.
Tunneled Central Venous Catheters
Tunneled central venous catheters (TCVC) are designed for intermediate-to long-term regular central venous access, for example, in the setting of hemodialysis. These catheters have a subcutaneous tunnel from the point of venous puncture to the site where the catheter exits the skin. Just under the skin exit site, the catheter has a circumferential cuff that allows for the body to incorporate it into the tissue of the tunnel, which typically takes at least 2 weeks and reduces the risk of accidental removal, as well as serving as a physical barrier to infection.
The size of the catheter required depends on patient size and the intended use for the catheter. Ideally, a 5F catheter should be used for nondialysis pediatric patients unless they are of a significant size. Dialysis catheters do not need to be as large as adult catheters because the flow rates required are typically less than in the adult setting. The right internal jugular vein is the preferred venous access site; however, this choice depends on a variety of things, including the presence of cardiac anomalies and the possible future need for arteriovenous fistula formation. TCVC also can be placed into the femoral, hepatic, renal, external jugular, subclavian, and thoracic collateral venous circulation as well as directly into the inferior vena cava (IVC). Ideally, the tip of a hemodialysis catheter should be in the right atrium, whereas, an infusion TCVC can have its tip at the right atrial-caval junction (Figure 2 ).
Implantable Venous Access Ports
Implantable ports consist of a central venous catheter connected to a subcutaneous port. The port consists of a small reservoir with a firm floor and an anterior septum, which simplifies safe needle puncture. Because there is no cutaneous component, ports are best suited to patients who require intermittent venous access over an extended period of time. The most common indication is chemotherapy; however, they also are useful in patients who require occasional courses of intravenous medication, such as antibiotics for infections (such as patients with cystic fibrosis) [1] . Ports are usually placed between the subcutaneous fat and muscle of the anterior chest wall. They may be placed in the upper arm in smaller children; however, this puts the overlying skin at risk for pressure necrosis [6] .
Pediatric Angiography and Arterial Intervention
The indications for pediatric angiography and intervention are different for those in adults, both due to the absence of atherosclerotic disease and the inclusion of congenital disorders. Diagnostic angiography has largely been supplanted by CT and magnetic resonance angiography except in certain circumstances in which the resolution of conventional angiography still makes it the criterion standard. Examples include the workup of renovascular hypertension, assessment for cerebral vascular pathology (such as vasculitis), and mapping of peripheral vessels for limb reconstruction ( Figure 3 ) [7] . Catheter-based arterial intervention includes organ and peripheral embolization, angioplasty, and thrombolysis.
Guidelines that cover pediatric arterial access and arteriography have recently been published, in collaboration, by the Societies for Interventional Radiology and Pediatric Radiology [8] . These guidelines cover aspects that include radiation protection, preprocedure preparation, contrast media, indications, arterial access, and angiography injection parameters. Low-osmolar nonionic contrast should be used, and doses should be limited to 4-5 mL/kg for neonates and 6-8 mL/kg for older children [8] . In neonates, aspirating the contrast from the dead space of the catheter reduces the contrast load. Neonates also are at risk of anemia, fluid overload, and hypothermia from excessive saline solution flush, which necessitates careful management of all administered and/or aspirated fluid and blood. A premature neonate who weighs 1.5 kg has a circulating blood volume of approximately 147 mL (98 mL/kg at 72 hours of age [9] ).
Most invasive arterial procedures are performed by a common femoral artery puncture. Other access arteries are occasionally used, including umbilical arteries in neonates. All arterial punctures should be performed with the patient under ultrasound guidance. Reducing the access sheath diameter relative to the artery diameter reduces the risk of arterial spasm and thrombosis [10] . In cases in which thrombosis is a significant risk, systemic heparinization (75-100 IU/kg) is recommended [8] . At the end of the procedure, hemostasis can be easily achieved with manual compression. However, care must be taken to avoid arterial thrombosis due to overcompression, which can best be achieved by monitoring distal pulses, capillary refill, and skin colour during compression.
Renal Angiography and Intervention
The most common indication for renal angiography is renovascular hypertension. Up to 25% of pediatric patients with hypertension have a renovascular cause, the most common being fibromuscular dysplasia [7] . Renal angiography remains the criterion standard because it is able to identify segmental stenoses, which are often missed on noninvasive cross-sectional imaging. Occasionally, renal vein sampling can be used to try and localize the source of abnormal renin production. Renal artery stenoses, particularly due to fibromuscular dysplasia and neurofibromatosis type 1, can be treated successfully with angioplasty ( Figure 4 ). Transplant renal artery stenoses are also very amenable to angioplasty with stenting as required. A near 100% technical success rate corresponds to a hypertension improvement or cure in 54%-94% of patients [11] . Rarely, renal ablation is performed in patients with severe hypertension and a single atrophic kidney ( Figure 5 ).
Cerebral Angiography and Intervention
Diagnostic cerebral angiography has largely been replaced by imaging modalities such as CT angiography and MR angiography. The diagnosis of certain pathologies, however, necessitates small-vessel assessment, and, at this time, cerebral angiography often provides the required resolution in the workup of vasculitis, spinal arteriovenous (AV) shunts, cerebral aneurysms, and AV malformations (AVM) in many cases, especially in smaller children ( Figure 6 ) [12] . In addition, a variety of catheter-based interventions are now commonplace, including treatment of vascular lesions, such as aneurysms and AVMs, preoperative embolization of tumours, functional testing (eg, Wada test), and treatment of acute ischemic stroke. Pediatric cerebral angiography is a very low risk procedure, with stroke being the most feared complication. Postprocedure seizures, transient cortical blindness, or encephalopathy occur rarely [12] .
Hepatosplenic Vascular Intervention
There are various indications for hepatic intervention in the pediatric population. These include embolization of hepatic vascular malformations and/or tumours, and traumatic hemorrhage, treatment of posttransplant hepatic artery stenosis, chemoembolization of hepatic tumours, and transjugular intrahepatic portosystemic shunt (TIPS) for portal hypertension.
Liver Transplantation Intervention
Hepatic artery stenosis occurs after liver transplantation at the arterial anastomosis in up to 20% of patients [13] . Hepatic artery thrombosis occurs in approximately 10%. Because most stenoses occur within the first 3 months after transplantation, monitoring with ultrasound is essential to avoid progression to thrombosis, which can result in significant patient mortality. Angioplasty for hepatic arterial stenosis in this setting is best performed by using a transfemoral approach. In cases of a borderline stenosis, a pressure gradient greater than 10 mm Hg across the stenosis is an indication for treatment [14] . Stent deployment should generally be avoided in the pediatric population and be reserved for severe recurrent stenoses or angioplasty complications. Thrombolysis can be attempted in cases of acute hepatic artery thrombosis. Balloon angioplasty is also the treatment of choice for both hepatic and portal venous stenoses [14] .
Hepatic Chemoembolization
Transcatheter arterial chemoembolization (TACE) is a local therapeutic technique widely used in the treatment of liver tumours, particularly hepatocellular carcinoma in the adult population. It uses the fact that hepatic tumours derive the majority of their blood supply (approximately 95%) from the hepatic artery, unlike the normal liver, which is supplied mainly from the portal vein [15] . The chemotherapeutic is combined with an embolic platform and is injected into the segmental or lobar hepatic arteries that supply the tumour. Various embolic platforms exist, including ethiodized oil such as Lipiodol (Guerbet, Roissy CdG Cedex, France) and microspheres. In cases in which lipiodol is used, another embolic is injected after the chemotherapeutic-lipiodol emulsion to reduce chemotherapeutic washout and systemic exposure. Although TACE is a palliative technique, it can downstage the tumour, potentially allowing curative treatment with liver resection or transplantation [16, 17] .
In the pediatric population, chemoembolization has been used successfully to treat primary hepatic malignancies, such as hepatoblastoma ( Figure 7 ) as well as liver metastases [15] . Cisplatin-Doxorubicin-Lipiodol TACE has been used to successfully downstage hepatoblastomas, which allowed resection in 13 of 16 patients in one series [17] . Despite this, event-free survival remained less than 44% at 5 years, predominantly due to micrometastases. Similar findings have been seen elsewhere [18] .
TIPS
TIPS is an uncommon procedure used in the treatment of complications related to portal hypertension that occur in the setting of end-stage liver disease. Indications for the treatment of portal hypertension with TIPS mirror those of adults and include life-threatening variceal hemorrhage and intractable ascites. It can be used as a form of primary palliation or as an alternative to surgical shunt placement in patients awaiting liver transplantation. Causes of pediatric portal hypertension potentially treated with TIPS include biliary atresia, cystic fibrosis, congenital hepatic fibrosis, a-1-antitrypsin deficiency, transplant graft rejection, and viral or autoimmune hepatitis [19] .
TIPS involves the endovascular creation of a shunt between the portal and hepatic veins ( Figure 8 ). This is performed, as the name suggests, by using a transjugular approach to cannulate the portal vein from the hepatic vein. The hepatic tract is then balloon dilated and stented. Although partially covered stents, such as the Viatorr stents (WL Gore, Flagstaff, AZ), are used in the adult population, they can be too large for pediatric patients undergoing TIPS, which requires placement of covered and uncovered selfexpanding stents. Depending on the stent used, there is potential for stent dilation as the child grows. The procedure is performed mainly with fluoroscopy; however, ultrasound can be used to help cannulate the portal vein. The aim is to reduce the portosystemic gradient to less than 12 mm Hg. Reported technical success in children ranges from 78%-100% [19, 20] . Complications include bleeding, hepatic encephalopathy, shunt stenosis and/or thrombosis, sepsis, pulmonary oedema, or right heart failure, IVC thrombosis and death [19] . Due to the smaller size of the pediatric stents used, regular follow-up with ultrasound is required so that any signs of stenosis can be treated with early intervention. Despite this, patency rates up to 81 months have been reported [21, 22] .
Splenic Embolization
Splenomegaly Splenic sequestration due to splenomegaly can occur in patients with portal hypertension, which result in up to 90% of thrombocytes being removed from the circulation [23] . Other causes of splenomegaly-related thrombocytopenia include thalassemia major, osteomyelosclerosis, chronic idiopathic thrombocytopenic purpura, and viral infections such as Epstein Barr virus. Partial splenic embolization (PSE) is an alternative to surgical splenectomy. It avoids the risks of overwhelming infection in the setting of total splenectomy by leaving residual splenic tissue as well as being a minimal invasive treatment that can be repeated as necessary.
PSE is an inpatient procedure that involves careful patient preparation and vigilant postprocedure care. It is recommended that approximately two-thirds of the spleen be embolized to achieve the desired benefit with respect to platelet count elevation; however, this results in a significant ischemic burden with attendant postembolization syndrome (elevated white blood cell count, fever, and pain). Antibiotic coverage is essential, and some centres also use pneumococcal, meningococcal, and hemophilus immunization. Postembolization syndrome with significant abdominal pain is common, often requiring hospital admission for up to 1-2 weeks [24] . Embolic particles (typically 300-500 mm in diameter) are administered into the second-order branches of the splenic artery until near stasis (Figure 9 ). Some researchers have suspended the embolic particles in a mixture of contrast, penicillin, gentamicin, and lidocaine to provide further antibiotic cover [23, 24] .
The procedure is technically successful in 100%, with 70% of patients maintaining platelets counts higher than 100,000 per mm 3 at 5 years [25] . Thrombocytopenia can recur in 30% of patients after 1 episode of PSE; however, the procedure can be successfully repeated. It has been reported that TIPS does not have any significant effect on hypersplenism and has minimal improvement on platelet values [21] . However, PSE can reduce portal venous pressure with the suggestion that this may reduce the risk of variceal hemorrhage in patients with portal hypertension [23] .
Trauma
Splenic injury is the most common solid abdominal visceral injury in children [26] . Because the risk of overwhelming postsplenectomy infection is higher in children than in adults, splenectomy should be avoided when possible [27] . Splenic embolization is recognized by surgeons as a management strategy for the treatment of traumatic pediatric splenic hemorrhage [28] . A hemodynamically stable patient can be treated conservatively; however, splenic embolization should be considered in patients who are unstable or in those requiring ongoing transfusions. Splenic embolization combined with conservative management can result in splenic preservation in 97% of patients [26] . The optimal treatment of splenic artery pseudoaneurysms (SAP) is uncertain. In the adult population, SAPs are often associated with delayed rupture; however, this may not be the case for children, due to the thicker splenic capsule and more elastic parenchyma [29] . Although researchers have reported on successful embolization of pediatric SAP, with 76% of SAP undergoing embolization in one review, there is not enough good outcome data at present to offer a general consensus on how these should be managed [29] .
The aim of splenic embolization is to treat the focal hemorrhage or SAP, sparing the rest of the spleen (Figure 10 ). It usually is performed with coils; however, other agents, including liquid adhesive agents (such as n-butyl cyanoacrylate) can also be used. Although postembolization pain from partial splenic infarction is common, other complications, such as splenic failure and abscess formation, are rare.
Arterial Embolization for Hemorrhage
Arterial embolization is a treatment for hemorrhage commonly performed in the adult population, particularly for traumatic, gastrointestinal (GI), or pulmonary hemorrhage. However, although some of the indications are similar in the pediatric population, there are important differences.
Embolization for GI hemorrhage in pediatric patients is rare, with few case reports. Upper GI hemorrhage due to gastritis or peptic ulcers is uncommon compared with the adult population and has been embolized with varying degrees of success [30, 31] . Other causes of GI hemorrhage, such as intussusception or Meckel diverticulum, have a distinct cause that is better treated in a different fashion than embolization [32] . Technical difficulties related to pediatric artery size and the need for peripheral embolization make embolization in young children extremely challenging.
Causes of pediatric pulmonary hemorrhage include infection, cystic fibrosis, bronchiectasis, tuberculosis, foreign-body aspiration, and congenital heart disease [33] . Minor hemoptysis is almost always treated conservatively. Massive hemoptysis, defined as >8 mL/kg or 200-300 mL every 24 hours, requires more aggressive management [33e35]. Bronchial artery embolization (BAE) should be considered if bleeding continues despite bronchoscopic treatment. BAE also is useful in cases of chronic hemoptysis, such as cystic fibrosis [36] .
The bronchial arteries have variable origins but conventionally arise from the anterolateral descending thoracic aorta at the T5 and T6 levels. There often is recruitment of systemic arteries to the pulmonary circulation, which also need to be embolized, if safe to do so. Great care needs to be taken to identify and avoid embolizing any arteries that supply the spinal cord. Embolization is typically performed with 300-500 mm particles. Clinical success occurs in approximately 90% of pediatric and adult patients with cystic fibrosis [33, 34, 37] . However, up to half of these require further BAE [37] . Apart from chest pain, complications specific to BAE are rare but include dysphagia, spinal cord ischemia, aortic necrosis, bronchial necrosis, pulmonary infarction, and bronchoesophageal fistula.
Interventional Treatment of Vascular Malformations
Vascular malformations are subdivided into high-and low-flow malformations. The classic high-flow vascular malformation is the AVM, with capillary malformations occurring much more rarely. Low-flow malformations include venous, lymphatic, and mixed venolymphatic malformations. Diagnosis is usually made on the basis of clinical examination combined with imaging. Ultrasound, with Doppler interrogation, is used to assess many malformations, especially those situated superficially. Because the clinically obvious portion of any malformation may represent the ''tip of the iceberg,'' cross-sectional imaging (usually magnetic resonance imaging) is often performed. Low-flow malformations, such as venous and lymphatic malformations, are classically hyperintense on T2-weighted imaging and may have foci of hypointensity within them due to the presence of phleboliths. AVMs are high-flow lesions and, therefore, usually hypointense on T2-weighted imaging, with associated flow voids. Treatment, whether conservative, surgical, or radiologic, depends on many factors. At our institution, patients with these malformations are reviewed by the Vascular Anomalies Clinic, composed of a multidisciplinary team, including radiology (including diagnostic and interventional radiologists), plastic surgery, dermatology, and other clinical services relevant to the care of these patients. Individual treatment plans are then developed, with specific management strategies and long-term imaging follow-up reviewed on a formal basis at regular intervals.
AVMs
An AVM is an abnormal connection of arteries and veins, without an intervening capillary bed, which results in a simple or complex network of connecting vessels called a nidus (Figure 11 ). Of AVMs, 40% are detected at birth, and they occur more often in the pelvis and limbs [38] . Symptoms depend on the location and size of the AVM but can result from pressure effects, bleeding, venous hypertension, and AV shunting [39] .
Interventional treatment of AVMs can be performed from an arterial, venous, or combined approach. The aim, to treat the nidus, is the same. Proximal or distal embolization (ie, non-nidal embolization) results in a higher incidence of subsequent vascular recruitment and recurrence. Various embolics can be used, including coils, liquid adhesive agents, medical-grade alcohol, and Onyx (Covidien, Irvine, CA). Because many AVMs are complex, with multiple feeding arteries, draining veins and nidi, multiple treatments may be required. Staged sessional treatment can reduce the risk of complications in this setting, including tissue ischemia and nontarget embolization. 
Pulmonary AVM
Although pulmonary AVMs (PAVM) can occur in a nonsyndromic fashion, they are often seen in patients with hereditary hemorrhagic telangiectasia. PAVMs occur in a third of patients with hemorrhagic telangiectasia which itself affects 200 people per million [34] . PAVM can cause hypoxemia, cerebrovascular ischemia, brain abscesses, and pulmonary hemorrhage. Cerebrovascular events occur in approximately 25% of patients with PAVM due to right-toleft shunting, from pulmonary artery to vein, of venous emboli without the usual filtering by the pulmonary capillary bed [40] .
PAVMs are usually detected due to their complications; however, patients with hemorrhagic telangiectasia should be screened regularly [34] . Pulse oximetry detects any significant hypoxemia and CT can then be used to assess the number and location of any PAVM. The general rule is to treat any PAVM with a feeding artery of more than 3-mm diameter. Follow-up CT should be avoided in children, and, therefore, an exercise stress test with oximetry can be used to assess for any significant right-to-left shunt.
Embolization of pediatric PAVM is almost always done as an inpatient procedure with the patient under general anesthesia. General anesthesia with intubation enables the suspension of respiration and thus optimizes imaging. Access to the pulmonary artery is obtained via the femoral venous approach. A guide catheter or long sheath can then be used to allow stable access to the target pulmonary circulation. Historically, embolization of the feeding arteries of the PAVM has been performed by using coils; however, the introduction of Amplatzer vascular plugs (St Jude Medical, St Paul, MN) can achieve rapid occlusion of a target feeding artery with a single device ( Figure 12 ) [41] . Complications include paradoxical embolization of a coil or plug, angina, transient ischemic attack, and pleurisy. Follow-up is essential to monitor the growth of any sub-3-mm unoccluded PAVMs.
Vein of Galen Malformation
Vein of Galen malformations are quite rare, accounting for less than 1% of all cerebral AVMs [42] . Clinical manifestations depend upon the degree of AV shunting and commonly present in the neonate as congestive cardiac failure, with a mortality without treatment approaching 100% [43] . The diagnosis is sometimes made antenatally on ultrasound due to hydrocephalus, intracranial hemorrhage, or cardiomegaly, with fetal hydrops [44] . Embolization is a very successful procedure that has been shown to result in a neurologically normal outcome in 74% of treated patients [45] . The management of Vein of Galen malformations is extremely challenging and technically demanding. The decision as to when to treat patients depends on the severity of symptoms, and there are excellent guidelines in the literature [45] . The procedure is performed transarterially, and various embolics, including coils and glue, have been shown to be effective ( Figure 13 ) [43, 45] .
Venous Malformations
Venous malformations (VM) represent the most common vascular malformation, with a prevalence of 1% [46] . These malformations consist of an abnormal network of veins that have a variable appearance and can focally or diffusely involve adipose tissue, muscle, and other tissues, often crossing fascial planes. Approximately 40% occur in the head and neck, with a similar percentage occurring in the extremities [46] . All are present from birth, and they tend to grow in proportion to patient growth. The majority are spontaneous; however, some are associated with syndromes such as Klippel-Tr enaunay, Maffucci, and blue-rubber bleb nevus [46] . Symptoms typically result from mass effect, local tissue involvement, venous distension, venous stasis, and, rarely, hemorrhage. However, in many cases, the primary complaint is the poor cosmetic appearance of VMs. As with AVMs, it is important to have a multidisciplinary approach, and a formal vascular anomalies clinic is ideal. This provides a surrounding where both the patient's and their parent's expectations can be explored, especially regarding cosmesis. Many VMs require multiple treatments over years with palliation of symptoms. Surgical excision is not considered first-line management. Medical photography provides, in our opinion, an essential record of treatment.
Percutaneous sclerotherapy is considered first-line treatment for VM and is performed under fluoroscopic and/or ultrasound guidance. Simple VMs can be treated as outpatient procedures by using sedation. Sclerotherapy with ethanol can be exceedingly painful and always requires general anesthesia. Its use should be avoided around nerves. Due to the risk of hemoglobinuria, adequate hydration is essential, with larger VMs treated with alcohol. Sodium tetradecyl sulfate is another commonly used sclerosant and can be foamed for easy visualization under ultrasound. Other sclerosing agents include doxycycline, bleomycin, ethanolamine oleate, polidocanol, alcoholic solution of Zein, and sodium morrhuate [38] . Multiple areas of the VM can be treated in one sitting; however, care must be taken to avoid superficial injections, which can result in skin ischemia and necrosis. Complications after percutaneous sclerotherapy include skin erythema, necrosis, hyperpigmentation, hemoglobinuria, thrombophlebitis, and thromboembolism [46, 47] . Intravenous ethanol also can cause pulmonary arterial vasospasm, cardiopulmonary collapse, hyperthermia, intoxication, and bronchospasm [38] .
Lymphatic Malformations
Lymphatic malformations (LM) consist of an abnormal collection of dilated lymphatic channels. They present as soft 
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nonpulsatile masses, typically identified in the neonate or child. The majority occur in the head and neck region [38] . They can range tremendously in size and may require treatment due to mass effect, cosmetic appearance, bleeding, or infection. LMs are subdivided into macrocystic, microcystic, and mixed LMs, and have been called cystic hygromas and cavernous lymphangiomas, although these terms are discouraged. Sclerotherapy can be successful at treating LMs, especially those of the macrocystic variety ( Figure 14 ) [48] .
Sclerotherapy involves aspirating the LM and injecting a sclerosant such as doxycycline or bleomycin. Another successful option that does not require complete aspiration is OK-432 (Picibanil; Chugai Pharmaceuticals, Tokyo, Japan). OK-432 is a lyophilized mixture of group A Streptococcus pyogenes incubated with benyzlpenicillin ( Figure 15 ). It is thought to work by stimulating the production of cytokines, which produces a local cellular inflammatory reaction [38, 49] . OK-432 commonly causes fever, inflammation, and swelling. OK-432 and bleomycin have very similar success rates for macrocystic lesions, at more than 80%. Bleomycin also can cause fever. However, a rare but potentially lifethreatening risk associated with bleomycin use is pulmonary fibrosis [48, 49] , which requires a rigorous presclerotherapy assessment, as well as specific dose limits, both for each session, and for lifetime. Patients undergoing treatment in the head and neck benefit from admission to monitor for any airway compromise.
Venous Intervention
Pediatric venous thromboembolism (VTE) is uncommon, with a diagnosis rate of 4.9 per 100,000 hospital children per year [50] . VTE is more common in children under the age of 1 year and those 15 years of age and older, especially female patients. The backbone of treatment for VTE is anticoagulation; however, post-thrombotic syndrome can cause considerable morbidity. Thrombolysis should be considered in patients with ileofemoral deep venous thrombosis (DVT), central venous thrombosis, IVC thrombosis, bilateral renal vein thrombosis, AV fistula graft occlusion, and phlegmasia cerulea dolens [51, 52] . Thrombolysis can be performed mechanically or, in the absence of contraindications, with the addition of a thrombolytic, such as alteplase (dosing in the range of 0.03-0.1 mg/kg/h; maximum of 1-2 mg/h) [51] . There are various thrombectomy devices on the market, which range from simple infusion catheters to complex devices, such as the Angiojet (Possis Medical, Minneapolis, MN) and the Trellis (Bacchus Vascular, Santa Clara, CA). After the procedure, the patient should be admitted to a critical care setting to carefully monitor infusion rates and assess for potential complications. After initial catheterdirected treatment, an infusion of thrombolytic is often performed, with reassessment venography at 24 hours. If successful, then any underlying venous stenosis should be treated, followed by long-term anticoagulation. If there is no improvement in the appearance of the thrombus at 24 hours, then it is unlikely that continuing treatment will have any success. However, with a partial response, thrombolysis can be continued for 48-72 hours. The most common complication is bleeding, with major bleeding occurring in 15% of cases but with no fatalities [53] .
IVC filters have similar indications, regardless of patient age. These primarily include DVT with a contraindication to anticoagulation or pulmonary embolism (PE) despite anticoagulation [52, 54] . More controversial indications include floating DVT and a high risk of DVT, with contraindication to anticoagulation, such as patients with polytrauma. IVC filters have also been placed in the setting of PE prevention when treating large VMs, where there is risk of thromboembolic complications. Retrievable filters should always be used with the aim of removing them as soon as possible. The suitability of IVC filters for young children is uncertain because there is a minimum IVC size for most filters. There also are minimal long-term outcome data for pediatric patients; however, in a small series of 11 patients, there were no PEs [54] . A Gunther Tulip filter (Cook, Bloomington, IN) has been placed in 3 young pediatric patients, with the smallest IVC in a 2-year old patient that measured 5 mm in diameter [55] . The filter was removed successfully when no longer needed.
Conclusion
There are a wide range of vascular interventional radiology procedures that have either subtle or major variations when performed in the pediatric population compared with the adult population. Knowledge of these procedures, the variations, and the complications are essential for a radiologist involved in any centre that deals with pediatric patients. Radiologists can then guide clinicians with regard to the services interventional radiology can offer their patients. They also can correctly interpret any complications, reducing patient morbidity and mortality.
